Optimal schedule for anthracyclines
- 28 February 1985
- journal article
- editorial
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 21 (2) , 159-161
- https://doi.org/10.1016/0277-5379(85)90167-1
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- A Hypothesis Concerning the Effect of Changes in Scheduling upon the Cardiotoxicity of AdriamycinOncology, 1983
- Reduction of Doxorubicin Cardiotoxicity by Prolonged Continuous Intravenous InfusionAnnals of Internal Medicine, 1982
- Doxorubicin Cardiotoxicity: Assessment of Late Left Ventricular Dysfunction By Radionuclide CineangiographyAnnals of Internal Medicine, 1981
- An effective low-dose adriamycin regimen as secondary chemotherapy for metastatic breast cancer patientsCancer, 1980
- Adriamycin chemotherapy—efficacy, safety, and pharmacologic basis of an intermittent single high-dosage scheduleCancer, 1974
- Phase II evaluation of adriamycin in human neoplasiaCancer, 1973
- Pharmacokinetics and metabolism of adriamycin in manClinical Pharmacology & Therapeutics, 1973